Even as the clinical community works to establish the long-term benefits of current GLP-1 and HRT combinations, a new generation of metabolic therapies is already moving through trials, ones that extend the biological logic of this article's central argument into territory that semaglutide and tirzepatide alone cannot reach
Kong QL, Hu LJ, Cao JY, Huang YJ, Xu LH, Liang Y, et al
Understanding different water choices helps you decide which option supports your method
A magic pill is not available to cure obesity, a condition affecting more than 40% of adults in the U.S
The sodium chloride can interfere with certain peptide structures
GLP-1 receptor agonists as promising anti-inflammatory agents in heart failure with preserved ejection fraction